Abstract
ObjectivesMutations of BRCA1/2 improve cancer prognosis due to their better response to platinum-based chemotherapy. To appropriately evaluate the influence of pathogenic BRCA1/2 mutations on survival outcomes, various clinical factors related...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
